Welcome to Our Newest Member Sam Callisto
August 1, 2018
Samuel is a PhD Candidate in the Experimental and Clinical Pharmacology department. During his time in the program Samuel has pursued various avenues of research related to precision medicine in neuropharmacology with a focus on anti-seizure drugs. Projects include the effect of patient demographics on likelihood of experiencing side effects from topiramate, the pharmacogenomic underpinnings of lamotrigine clearance changes during pregnancy, and clinical applications of pharmacogenomics to epilepsy treatment. Samuel is currently investigating the role that neural activity plays in experiencing impaired cognition while taking topiramate.